CAPR — Capricor Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $170.43m
- $134.32m
- $25.18m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 9.89 | 32.7 | 34.9 | 41.4 | 39.5 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.088 | 0 | 0.392 | 0.548 | 10.4 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 10.5 | 33.7 | 36.4 | 42.9 | 50.9 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.443 | 0.851 | 4.62 | 6.94 | 7.61 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 11.1 | 34.6 | 41.3 | 50.1 | 58.7 |
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.898 | 2.97 | 4.13 | 23.6 | 31.3 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 4.27 | 6.42 | 9.96 | 38.3 | 36.1 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 6.84 | 28.2 | 31.4 | 11.8 | 22.6 |
Total Liabilities & Shareholders' Equity | 11.1 | 34.6 | 41.3 | 50.1 | 58.7 |
Total Common Shares Outstanding |